November 9, 2020
Mayo Clinic Research in the news — 11/9/2020
As SARS-CoV-2 spreads throughout the world, COVID-19 has become the subject of almost every conversation. Not surprisingly, the media are actively following developments in research on symptoms, testing, treatment and vaccines. In addition to some of these stories, you’ll find Mayo Clinic research and researchers highlighted across a wide range of topics. We are also […]
Tags: ALS, Alzheimer's disease, amyotrophic lateral sclerosis, animal model, ASTRO, bone disease, cancer screening, cardiovascular medicine, clinical research, colorectal cancer, COVID-19, David Ahlquist
August 21, 2020
Mayo Clinic Research in the news — 8/21/2020
A wide range of Mayo Clinic expertise was highlighted in the past week, with local, national and international media outlets quoting researchers and referring to Mayo Clinic research findings. Following are a selection of these news articles, with a brief excerpt and link to the full story on the appropriate websites. For ease of review, […]
Tags: Alzheimer's disease, Andrew Badley, blood pressure, Bobbi Pritt, Brian Mohney, cardiology, Centers for Disease Control and Prevention, COVID-19, diabetes, emergency department, epidemiology, genetics
December 11, 2018
New Mayo research focused on how women’s hormones affect aging
By Advancing the Science contributor
By Heather Carlson Kehren Mayo Clinic researchers are taking a closer look at differences in how women age and the role hormones may play in the process. To do that, they will focus on premenopausal women who have had both of their ovaries removed. Investigators will be looking to see how this abrupt loss of […]
Tags: Alzheimer's disease, Center for the Science of Health Care Delivery, Michelle Mielke, Rochester Epidemiology Project, women's health
August 24, 2017
UNTANGLING ALZHEIMER’S–Mayo Clinic’s approach
Families living with Alzheimer’s disease woke to devastating newspaper headlines recently: Another highly touted drug failed in clinical trials. Drugmaker Eli Lilly’s EXPEDITION3 trial tested an antibody, a molecule used by the immune system to fight off disease, called solanezumab. This experimental drug sought to remove harmful proteins in the brain that become building blocks for amyloid, […]
Tags: Alzheimer's disease, Michelle Mielke, Rochester Epidemiology Project